Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

AIM/CNSL stock hub

AIM/CNSL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/CNSLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.1M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/CNSL

In the news

Latest news · AIM/CNSL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/E3.8

P25 15.9P50 22.9P75 35.8

ROE13.3

P25 -54.2P50 2.1P75 13.7

ROIC-7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/CNSL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

GBP

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	84
Employees Change	-10%
Employees Change Percent	-10.64
Enterprise value	GBX 1.8M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	GB00B1VCP282
Last refreshed	2026-05-10
Market cap	GBX 5.1M
Price	GBX 2.08
Price currency	GBX
Rev Per Employee	95,940.48x
Sector	Healthcare
Sic	2835
Symbol	aim/CNSL
Website	https://www.cnsplc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	26.68%
EV Earnings	1.29x
EV/FCF	-3.25x
EV/Sales	0.22x
FCF yield	-10.57%
P/B ratio	0.46x
P/E ratio	3.75x
P/S ratio	0.63x
PE Ratio3 Y	14.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.7%
EBITDA Margin	-4.05%
Gross margin	66.44%
Gross Profit	GBX 5.4M
Gross Profit Growth	-1.6%
Gross Profit Growth Q	-3.22%
Gross Profit Growth3 Y	-3.97%
Gross Profit Growth5 Y	8.6%
Net Income	GBX 1.4M
Net Income Growth	684.48%
Net Income Growth Years	3%
Pretax Margin	16.94%
Profit Margin	16.94%
Profit Per Employee	GBX 16,250
Profitable Years	1
ROA	-2.58
Roa5y	-3.49
ROCE	-4.85
ROE	13.26
Roe5y	-4.71
ROIC	-7.02
Roic5y	-12.09

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-18.56%
Cagr15y	-11.72%
Cagr1y	-18.64%
Cagr20y	-37.8%
Cagr3y	-6.02%
Cagr5y	-52.3%
EPS Growth	684.1
EPS Growth Years	3
Revenue Growth	-10.2x
Revenue Growth Q	-6.56x
Revenue Growth Years	0x
Revenue Growth3 Y	-6.23x
Revenue Growth5 Y	1.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.62
Assets	GBX 12.7M
Cash	GBX 3.6M
Current Assets	GBX 6.6M
Current Liabilities	GBX 1.6M
Debt	GBX 237,000
Debt Equity	GBX 0.02
Debt FCF	GBX -0.44
Equity	GBX 11.1M
Interest Coverage	-36
Liabilities	GBX 1.6M
Long Term Assets	GBX 6.1M
Long Term Liabilities	GBX 75,000
Net Cash	GBX 3.4M
Net Cash By Market Cap	GBX 65.62
Net Cash Growth	-24.41%
Net Debt Equity	GBX -0.3
Tangible Book Value	GBX 7.6M
Tangible Book Value Per Share	GBX 0.03
WACC	14.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.25
Inventory Turnover	3.59
Net Working Capital	GBX 1.6M
Quick ratio	3.79
Working Capital	GBX 5.1M
Working Capital Turnover	GBX 1.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-87.17%
1Y total return	-18.62%
200-day SMA	2.43
3Y total return	-17%
50-day SMA	1.94
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.53%
All Time High	32,592.6
All Time High Change	-99.99%
All Time High Date	2004-07-15
All Time Low	1.66
All Time Low Change	25.01%
All Time Low Date	2023-10-24
ATR	0.27
Beta	1.92
Beta1y	0.2
Beta2y	0.44
Ch YTD	6.42
High	2.08
High52	4.33
High52 Date	2025-07-02
High52ch	-52.11%
Low	2.08
Low52	1.7
Low52 Date	2026-04-16
Low52ch	22.07%
Ma50ch	6.96%
Price vs 200-day SMA	-14.53%
RSI	88.4
RSI Monthly	38.8
RSI Weekly	48.59
Sharpe ratio	-0.28x
Sortino ratio	-0.27
Total Return	-0.08%
Tr YTD	6.42
Tr15y	-84.58%
Tr1m	12.17%
Tr1w	1.22%
Tr3m	3.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -540,000
Operating margin	-6.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	187,617,311%
Net Borrowing	-224,000
Shares Insiders	0.81%
Shares Institutions	67.59%
Shares Out	237,950,660
Shares Qo Q	-0.13%
Shares Yo Y	0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -731,000
Average Volume	342,771.3x
Bv Per Share	0.05
CAPEX	GBX -271,000
Ch10y	-87.17
Ch15y	-84.58
Ch1m	12.17
Ch1w	1.22
Ch1y	-18.62
Ch20y	-99.99
Ch3m	3.76
Ch3y	-17
Ch5y	-97.53
Ch6m	-21.69
Change	-3.48%
Change From Open	0
Close	2.15
Days Gap	-3.49
Depreciation Amortization	214,000
Dollar Volume	287,160.6
Earnings Date	2026-07-24
EBIT	GBX -540,000
EBITDA	GBX -326,000
EPS	GBX 0.01
F Score	4
FCF	GBX -541,000
FCF EV Yield	-30.76x
FCF Per Share	GBX -0
Financing CF	-239,000
Fiscal Year End	March
Founded	1,987
Goodwill	3,017,000
Graham Number	7.741
Graham Upside	273
Investing CF	-371,000
Is Primary Listing	1
Last Earnings Date	2026-02-09
Last Report Date	2025-09-30
Last Split Date	2007-08-31
Last Split Type	Reverse
Ma150	2.14
Ma150ch	-3.17%
Ma20	2
Ma20ch	3.6%
Net CF	-926,000
Next Earnings Date	2026-07-24
Open	2.08
Ppne	845,000
Price Date	2026-05-08
Ptbv Ratio	0.67
Relative Volume	0.43x
Revenue	8,059,000x
SBC By Revenue	2.36x
Share Based Comp	190,000
Tr20y	-99.99%
Tr6m	-21.69%
Volume	138,384
Z Score	1.14

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/CNSL pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/CNSL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/CNSL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+67.6%

Share of float held by funds and institutions

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

AIM/CNSL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

88.4

Above 70: short-term overbought

Price vs 200-day MA

-14.5%

50/200-day relationship not available

Beta (5Y)

1.92

More volatile than the market

Sharpe ratio

-0.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/CNSL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/CNSL stock rating?

aim/CNSL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/CNSL analysis?

The full report lives at /stocks/aim/CNSL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/CNSL?

The latest report frames aim/CNSL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/CNSL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.